Literature DB >> 19406172

Proteolytic and non-proteolytic roles of membrane type-1 matrix metalloproteinase in malignancy.

Alex Y Strongin1.   

Abstract

This manuscript provides an overview of the dynamic interactions which play an important role in regulating cancer cell functions. We describe and discuss, primarily, those interactions which involve membrane type-1 matrix metalloproteinase (MT1-MMP), its physiological inhibitor tissue inhibitor of metalloproteinases-2 (TIMP-2), furin-like proprotein convertases and the low density lipoprotein-related protein 1 (LRP1) signaling scavenger receptor. The interaction among these cellular proteins controls the efficiency of the activation of MT1-MMP and the unorthodox intracellular signaling which is generated by the catalytically inert complex of MT1-MMP with TIMP-2 and which plays a potentially important role in the migration of cancer cells. Our in-depth understanding of these cellular mechanisms may provide the key to solving the puzzling TIMP-2 paradox. This unsolved paradox arises from the fact that TIMP-2 is a powerful inhibitor of MMPs including MT1-MMP, but at the same time high levels of TIMP-2 positively correlate with an unfavorable prognosis in cancer patients. Solving the TIMP-2 paradox may lead to solving a similar PAI-1 paradox and produce a clearer understanding of the biochemical mechanisms which control the functionality of the urokinase-type plasminogen activator*urokinase receptor*plasminogen activator inhibitor type-1 (uPAR*uPA*PAI-1) system in cancer. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19406172      PMCID: PMC2823998          DOI: 10.1016/j.bbamcr.2009.04.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  93 in total

1.  Low-density lipoprotein receptor-related protein-1 (LRP-1) expression in a rat model of oxygen-induced retinal neovascularization.

Authors:  María C Sánchez; Pablo F Barcelona; Jose D Luna; Susana G Ortiz; Patricio C Juarez; Clelia M Riera; Gustavo A Chiabrando
Journal:  Exp Eye Res       Date:  2006-09-15       Impact factor: 3.467

Review 2.  Mislocalization and unconventional functions of cellular MMPs in cancer.

Authors:  Alex Y Strongin
Journal:  Cancer Metastasis Rev       Date:  2006-03       Impact factor: 9.264

Review 3.  Proprotein convertases: lessons from knockouts.

Authors:  Nathalie Scamuffa; Fabien Calvo; Michel Chrétien; Nabil G Seidah; Abdel-Majid Khatib
Journal:  FASEB J       Date:  2006-10       Impact factor: 5.191

4.  The matrix metalloproteinase system in oral squamous cell carcinoma.

Authors:  E A Baker; D J Leaper; J P Hayter; A J Dickenson
Journal:  Br J Oral Maxillofac Surg       Date:  2005-12-09       Impact factor: 1.651

5.  ADAM12 is a four-leafed clover: the excised prodomain remains bound to the mature enzyme.

Authors:  Ulla M Wewer; Matthias Mörgelin; Peter Holck; Jonas Jacobsen; Magnus C Lydolph; Anders H Johnsen; Marie Kveiborg; Reidar Albrechtsen
Journal:  J Biol Chem       Date:  2006-02-02       Impact factor: 5.157

6.  The hemopexin and O-glycosylated domains tune gelatinase B/MMP-9 bioavailability via inhibition and binding to cargo receptors.

Authors:  Philippe E Van den Steen; Ilse Van Aelst; Vibeke Hvidberg; Helene Piccard; Pierre Fiten; Christian Jacobsen; Soren K Moestrup; Simon Fry; Louise Royle; Mark R Wormald; Russell Wallis; Pauline M Rudd; Raymond A Dwek; Ghislain Opdenakker
Journal:  J Biol Chem       Date:  2006-05-03       Impact factor: 5.157

7.  Tissue inhibitor of metalloproteinases-2 binding to membrane-type 1 matrix metalloproteinase induces MAPK activation and cell growth by a non-proteolytic mechanism.

Authors:  Silvia D'Alessio; Giovanni Ferrari; Karma Cinnante; William Scheerer; Aubrey C Galloway; Daniel F Roses; Dmitri V Rozanov; Albert G Remacle; Eok-Soo Oh; Sergey A Shiryaev; Alex Y Strongin; Giuseppe Pintucci; Paolo Mignatti
Journal:  J Biol Chem       Date:  2007-11-08       Impact factor: 5.157

8.  Low-density lipoprotein receptor-related protein promotes amyloid precursor protein trafficking to lipid rafts in the endocytic pathway.

Authors:  Il-Sang Yoon; Eunice Chen; Tracy Busse; Emanuela Repetto; Madepalli K Lakshmana; Edward H Koo; David E Kang
Journal:  FASEB J       Date:  2007-04-26       Impact factor: 5.191

9.  Clinical implications of HER-2/neu overexpression and proteolytic activity imbalance in breast cancer.

Authors:  Menha Swellam; Lobna R Ezz El Arab; Hussein A Bushnak
Journal:  IUBMB Life       Date:  2007-06       Impact factor: 3.885

10.  Proteolysis of the membrane type-1 matrix metalloproteinase prodomain: implications for a two-step proteolytic processing and activation.

Authors:  Vladislav S Golubkov; Alexei V Chekanov; Sergey A Shiryaev; Alexander E Aleshin; Boris I Ratnikov; Katarzyna Gawlik; Ilian Radichev; Khatereh Motamedchaboki; Jeffrey W Smith; Alex Y Strongin
Journal:  J Biol Chem       Date:  2007-10-15       Impact factor: 5.157

View more
  50 in total

1.  Membrane type-1 matrix metalloproteinase (MT1-MMP) correlates with the expression and activation of matrix metalloproteinase-2 (MMP-2) in inflammatory breast cancer.

Authors:  Diaa Al-Raawi; Helal Abu-El-Zahab; Mohamed El-Shinawi; Mona Mostafa Mohamed
Journal:  Int J Clin Exp Med       Date:  2011-10-11

2.  Potential relation of aberrant proteolysis of human protein tyrosine kinase 7 (PTK7) chuzhoi by membrane type 1 matrix metalloproteinase (MT1-MMP) to congenital defects.

Authors:  Vladislav S Golubkov; Alexander E Aleshin; Alex Y Strongin
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

3.  Novel MT1-MMP small-molecule inhibitors based on insights into hemopexin domain function in tumor growth.

Authors:  Albert G Remacle; Vladislav S Golubkov; Sergey A Shiryaev; Russell Dahl; John L Stebbins; Andrei V Chernov; Anton V Cheltsov; Maurizio Pellecchia; Alex Y Strongin
Journal:  Cancer Res       Date:  2012-03-09       Impact factor: 12.701

Review 4.  Semaphorins in angiogenesis and tumor progression.

Authors:  Gera Neufeld; Adi D Sabag; Noa Rabinovicz; Ofra Kessler
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

Review 5.  Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?

Authors:  Santiago Rivera; Michel Khrestchatisky; Leszek Kaczmarek; Gary A Rosenberg; Diane M Jaworski
Journal:  J Neurosci       Date:  2010-11-17       Impact factor: 6.167

6.  Intradomain cleavage of inhibitory prodomain is essential to protumorigenic function of membrane type-1 matrix metalloproteinase (MT1-MMP) in vivo.

Authors:  Vladislav S Golubkov; Andrei V Chernov; Alex Y Strongin
Journal:  J Biol Chem       Date:  2011-08-08       Impact factor: 5.157

7.  Cross-talk between clinical and host-response parameters of periodontitis in smokers.

Authors:  R Nagarajan; C S Miller; D Dawson; M Al-Sabbagh; J L Ebersole
Journal:  J Periodontal Res       Date:  2016-07-19       Impact factor: 4.419

8.  Phosphorylation of membrane type 1-matrix metalloproteinase (MT1-MMP) and its vesicle-associated membrane protein 7 (VAMP7)-dependent trafficking facilitate cell invasion and migration.

Authors:  Karla C Williams; Marc G Coppolino
Journal:  J Biol Chem       Date:  2011-10-14       Impact factor: 5.157

9.  MMP14 is a novel target of PTH signaling in osteocytes that controls resorption by regulating soluble RANKL production.

Authors:  Jesus Delgado-Calle; Benjamin Hancock; Elive F Likine; Amy Y Sato; Kevin McAndrews; Carolina Sanudo; Angela Bruzzaniti; Jose A Riancho; James R Tonra; Teresita Bellido
Journal:  FASEB J       Date:  2018-01-17       Impact factor: 5.191

10.  Smoking-related cotinine levels and host responses in chronic periodontitis.

Authors:  J L Ebersole; M J Steffen; M V Thomas; M Al-Sabbagh
Journal:  J Periodontal Res       Date:  2013-11-27       Impact factor: 4.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.